Marksans Pharma reports 37% fall in Q3 consolidated net profit

06 Feb 2017 Evaluate

Marksans Pharma has reported results for third quarter ended December 31, 2016.  

The company has reported 39.67% fall in its net profit at Rs 8.44 crore for the quarter under review as compared to Rs 13.99 crore for the same quarter in the previous year. Total income of the company decreased by 6.81% at Rs 64.58 crore for the quarter under review as compared Rs 69.30 crore for the corresponding quarter previous year. 

On the consolidated basis, the company has reported 36.98% fall in its net profit after taxes, minority interest and share of profit of associates at Rs 11.30 crore for the quarter ended December 31, 2016, as compared to Rs 17.93 crore for the same quarter in the previous year. Total income of the company decreased by 1.04% at Rs 215.25 crore for the quarter under review as compared Rs 217.51 crore for the corresponding quarter previous year. 

 

Marksans Pharma Share Price

183.95 -3.95 (-2.10%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×